CAS: 1935694-88-4
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Spartalizumab REF: TM-T77075CAS: 1935694-88-4 | SDS-PAGE:95.2%;SEC-HPLC:96.3% | 170.00 €~872.00 € | Mon 21 Apr 25 |
 | Spartalizumab REF: 3D-CLA1490CAS: 1935694-88-4 | - - - | To inquire | Tue 29 Apr 25 |
Spartalizumab
CAS:1935694-88-4
"Spartalizumab (PDR001), a humanized IgG4 monoclonal antibody, targets PD-1 to inhibit PD-L1/L2 interactions, useful in …
Purity:
SDS-PAGE:95.2%;SEC-HPLC:96.3%
Color and Shape:
Liquid
Molecular weight:
145.74 kDa
Ref: TM-T77075
| 1mg | 170.00 € | ||
| 5mg | 512.00 € | ||
| 10mg | 872.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
Spartalizumab
CAS:1935694-88-4
Monoclonal antibody targeting PD-1 (CD279), being researched for melanoma
Ref: 3D-CLA1490
| Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 29 Apr 2025
